Resonant
Erin Saito, PhD, is an accomplished professional currently serving as the Director of Medical Writing for Renew Biotechnologies, Resonant, and Wasatch Biolabs, all within the biotechnology sector. In these roles, Erin Saito focuses on developing innovative diagnostic solutions in personalized healthcare, particularly in the early detection of neurodegenerative diseases. Previously, Erin Saito worked as a Science Writer at Brigham Young University's College of Life Sciences, contributing to the communication of significant research in neuroscience and biology. Furthermore, Erin Saito conducted neurobiological research during doctoral studies at Brigham Young University, exploring the impacts of ketones on brain metabolism related to Alzheimer's disease. Erin Saito earned a PhD in Cell/Cellular and Molecular Biology from Brigham Young University, along with a BS in Biology from the same institution. Additional educational experience includes studies at UCLA.
This person is not in any teams
Resonant
Neurodegenerative disorders (NGDs) affect millions worldwide. Starting with Alzheimers, we are committed to creating novel testing solutions for early detection to provide clinicians, researchers, and individuals with the tools to effectively diagnose, treat, and manage NGDs.